According to BIS Research, the global cancer vaccine market was valued at $8.52 billion in 2023 and is expected to reach $19.46 billion by 2033, growing at a CAGR of 8.57% during the forecast period. This expansion is driven by breakthroughs in immunotherapy, rising cancer incidence, and increased R&D investments. 1. Market Overview Cancer vaccines